We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$3.9B
AUM Growth
+$207M
Cap. Flow
+$20.9M
Cap. Flow %
0.53%
Top 10 Hldgs %
34.23%
Holding
655
New
56
Increased
101
Reduced
142
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 22.14%
2 Healthcare 15.19%
3 Consumer Staples 14.02%
4 Industrials 13.53%
5 Consumer Discretionary 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
426
Ametek
AME
$59.3B
$49K ﹤0.01%
930
POR icon
427
Portland General Electric
POR
$5.74B
$49K ﹤0.01%
1,293
TEVA icon
428
Teva Pharmaceuticals
TEVA
$42.8B
$49K ﹤0.01%
850
TFI icon
429
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.17B
$48K ﹤0.01%
1,000
EEB
430
DELISTED
Invesco BRIC ETF
EEB
$48K ﹤0.01%
1,665
KEYS icon
431
Keysight
KEYS
$60.6B
$47K ﹤0.01%
+1,383
New +$45.2K
XLE icon
432
State Street Energy Select Sector SPDR ETF
XLE
$39.9B
$47K ﹤0.01%
+1,200
New +$49.9K
EPZM
433
DELISTED
Epizyme, Inc
EPZM
$47K ﹤0.01%
+2,500
New +$58.4K
FCEL icon
434
FuelCell Energy
FCEL
$1.73B
$46K ﹤0.01%
7
PODD icon
435
Insulet
PODD
$10.1B
$46K ﹤0.01%
1,000
BC icon
436
Brunswick
BC
$5.21B
$45K ﹤0.01%
870
BNY
437
Bank of New York Mellon
BNY
$111B
$45K ﹤0.01%
1,100
JEF icon
438
Jefferies Financial Group
JEF
$12.6B
$45K ﹤0.01%
2,234
XEL icon
439
Xcel Energy
XEL
$49.1B
$45K ﹤0.01%
1,245
MET icon
440
MetLife
MET
$61.4B
$44K ﹤0.01%
910
+30
+3% +$1.43K
MILL
441
DELISTED
MILLER ENERGY RESOURCES, INC COM STK
MILL
$44K ﹤0.01%
35,375
OZK icon
442
Bank OZK
OZK
$5.69B
$43K ﹤0.01%
+1,140
New +$39.8K
VA
443
DELISTED
Virgin America Inc.
VA
$43K ﹤0.01%
+1,000
New +$36.1K
FCX icon
444
Freeport-McMoran
FCX
$96.9B
$42K ﹤0.01%
1,800
DNB
445
DELISTED
Dun & Bradstreet
DNB
$42K ﹤0.01%
348
ITUB icon
446
Itaú Unibanco
ITUB
$81.6B
$41K ﹤0.01%
7,800
O icon
447
Realty Income
O
$59.2B
$41K ﹤0.01%
894
REGN icon
448
Regeneron Pharmaceuticals
REGN
$82.2B
$41K ﹤0.01%
+100
New +$39.3K
XYL icon
449
Xylem
XYL
$28.5B
$41K ﹤0.01%
+1,070
New +$39.1K
EV
450
DELISTED
Eaton Vance Corp.
EV
$41K ﹤0.01%
1,000

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Loring Wolcott & Coolidge Fiduciary Advisors held 655 positions worth $3.9B, up 5.6% from $3.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2014 filing shows 56 new, 101 increased, 142 reduced and 21 closed positions. Its largest new stake was CDK Global, Inc.: 455,470 shares worth $18.6M. The largest sale was Automatic Data Processing, an estimated $18M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2014 buy was CDK Global, Inc.: 455,470 shares worth $18.6M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Warner Bros in Q4 2014, an estimated $11.1M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2014 reduction was Automatic Data Processing, cutting an estimated $18M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited ANNIES INC COMMON STOCK (DE) in Q4 2014, selling an estimated $1.53M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 34% of its $3.9B portfolio in Q4 2014.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 56 new positions and closed 21 in Q4 2014.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 5.6% quarter-over-quarter to $3.9B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2014, filed 12 Feb 2015.